 <h1>Rimantadine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to rimantadine: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, rimantadine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking rimantadine:</p><p>
<i>Less common</i>
</p><ul>
<li>Difficult or labored breathing</li>
<li>shortness of breath</li>
<li>tightness in the chest</li>
<li>wheezing</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking rimantadine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Anxiety</li>
<li>chest pain or discomfort</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>hyperventilation</li>
<li>irregular heartbeats</li>
<li>irritability</li>
<li>lightheadedness</li>
<li>nervousness</li>
<li>pounding or rapid pulse</li>
<li>restlessness</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>shaking</li>
<li>trouble with sleeping</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of rimantadine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>acid or sour stomach</li>
<li>belching</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>diarrhea</li>
<li>difficulty with concentrating</li>
<li>headache</li>
<li>hearing loss</li>
<li>heartburn</li>
<li>impaired concentration</li>
<li>indigestion</li>
<li>lack or loss of strength</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>rash</li>
<li>shakiness and unsteady walk</li>
<li>sleepiness or unusual drowsiness</li>
<li>stomach discomfort, upset, or pain</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rimantadine: oral syrup, oral tablet</i></p><h3>General</h3><p>The more commonly reported adverse effects have included gastrointestinal and nervous system side effects.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Gait abnormality, hyperkinesia, tremor, taste loss/change, parosmia, and convulsions have been reported in less than 0.3% of patients.  Hypesthesia has occurred with higher than recommended doses.  Dizziness and headache were reported up to two times more often in geriatric patients receiving rimantadine than in those receiving placebo.  Seizures were reported in a few patients during clinical trials with rimantadine.  In two patients, seizure activity had been absent for greater than 10 years.  However, their anticonvulsant medications had been withdrawn in the previous few months.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dizziness, headache, jitteriness</p>
<p><b>Uncommon</b> (0.1% to 1%): Ataxia, somnolence </p>
<p><b>Frequency not reported</b>: Gait abnormality, hyperkinesia, tremor, taste loss/change, parosmia, convulsions, hypesthesia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting, anorexia, dry mouth, abdominal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dyspepsia</p>
<p><b>Frequency not reported</b>: Constipation, dysphagia, stomatitis<sup>[Ref]</sup></p><p>Constipation, dysphagia, and stomatitis have occurred with higher than recommended doses of rimantadine.  Gastrointestinal symptoms (particularly nausea, vomiting, and abdominal pain) were reported at least twice as often in geriatric patients receiving rimantadine than in those receiving placebo.  Tolerance may be improved by giving the drug in two divided daily doses.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, impaired concentration, nervousness, depression </p>
<p><b>Uncommon</b> (1% to 10%): Agitation </p>
<p><b>Frequency not reported</b>: Hallucinations, euphoria, anxiety, confusion</p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Cardiac failure, cerebrovascular disorder, heart block, hypertension, palpitation, pedal edema, tachycardia, syncope<sup>[Ref]</sup></p><p>Cardiac failure, cerebrovascular disorder, heart block, hypertension, palpitation, pedal edema, tachycardia, and syncope were reported in less than 0.3% of patients.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p>
<p><b>Frequency not reported</b>: Bronchospasm, cough<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, fatigue </p>
<p><b>Uncommon</b> (0.1% to 1%): Tinnitus </p>
<p><b>Frequency not reported</b>: Fever, rigors<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Diaphoresis, rash<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Nonpuerperal lactation, increased micturition frequency</p><p>Genitourinary side effects have included nonpuerperal lactation in less than 0.3% of patients.  Increased micturition frequency has occurred with higher than recommended doses of rimantadine.</p><h3>Ocular</h3><p><b>Frequency not reported</b>: Lacrimation, eye pain</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Flumadine (rimantadine)." Forest Pharmaceuticals, St. Louis, MO. </p><p id="ref_2">2. Centers for Disease Control and Prevention "Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP)." MMWR Morb Mortal Wkly Rep 47(RR-6) (1998): 1-26</p><p id="ref_3">3. Brady MT, Sears SD, Pacini DL, Samorodin R, DePamphilis J, Oakes M, Soo W, Clements ML "Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic." Antimicrob Agents Chemother 34 (1990): 1633-6</p><p id="ref_4">4. Jefferson T,  Demicheli V,  Rivetti D,  Jones M,  Di Pietrantonj C,  Rivetti A "Antivirals for influenza in healthy adults: systematic review." Lancet 367 (2006): 303-13</p><p id="ref_5">5. "Rimantadine for prevention and treatment of influenza." Med Lett Drugs Ther 35 (1993): 109-10</p><p id="ref_6">6. Patriarca PA, Kater NA, Kendal AP, Bregman DJ, Smith JD, Sikes RK "Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes." Antimicrob Agents Chemother 26 (1984): 101-3</p><p id="ref_7">7. Dolin R, Reichman RC, Madore HP, et al "A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection." N Engl J Med 307 (1982): 580-4</p><p id="ref_8">8. Millet VM, Dreisbach M, Bryson YJ "Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine." Antimicrob Agents Chemother 21 (1982): 1-4</p><p id="ref_9">9. Bentley DW, Karki SD, Betts RF "Rimantadine and seizures." Ann Intern Med 110 (1989): 323-4</p><p id="ref_10">10. Keyser LA, Karl M, Nafziger AN, Bertino JS "Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients." Arch Intern Med 160 (2000): 1485-8</p><p id="ref_11">11. Hayden FG, Hoffman HE, Spyker DA "Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics." Antimicrob Agents Chemother 23 (1983): 458-64</p></div>
<div class="more-resources" id="moreResources">
<h2>More about rimantadine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: adamantane antivirals</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Rimantadine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Flumadine</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Influenza A</li>
<li>Influenza Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rimantadine: oral syrup, oral tablet</i></p><h3>General</h3><p>The more commonly reported adverse effects have included gastrointestinal and nervous system side effects.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Gait abnormality, hyperkinesia, tremor, taste loss/change, parosmia, and convulsions have been reported in less than 0.3% of patients.  Hypesthesia has occurred with higher than recommended doses.  Dizziness and headache were reported up to two times more often in geriatric patients receiving rimantadine than in those receiving placebo.  Seizures were reported in a few patients during clinical trials with rimantadine.  In two patients, seizure activity had been absent for greater than 10 years.  However, their anticonvulsant medications had been withdrawn in the previous few months.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dizziness, headache, jitteriness</p><p><b>Uncommon</b> (0.1% to 1%): Ataxia, somnolence </p><p><b>Frequency not reported</b>: Gait abnormality, hyperkinesia, tremor, taste loss/change, parosmia, convulsions, hypesthesia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting, anorexia, dry mouth, abdominal pain</p><p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dyspepsia</p><p><b>Frequency not reported</b>: Constipation, dysphagia, stomatitis<sup>[Ref]</sup></p><p>Constipation, dysphagia, and stomatitis have occurred with higher than recommended doses of rimantadine.  Gastrointestinal symptoms (particularly nausea, vomiting, and abdominal pain) were reported at least twice as often in geriatric patients receiving rimantadine than in those receiving placebo.  Tolerance may be improved by giving the drug in two divided daily doses.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, impaired concentration, nervousness, depression </p><p><b>Uncommon</b> (1% to 10%): Agitation </p><p><b>Frequency not reported</b>: Hallucinations, euphoria, anxiety, confusion</p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Cardiac failure, cerebrovascular disorder, heart block, hypertension, palpitation, pedal edema, tachycardia, syncope<sup>[Ref]</sup></p><p>Cardiac failure, cerebrovascular disorder, heart block, hypertension, palpitation, pedal edema, tachycardia, and syncope were reported in less than 0.3% of patients.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p><p><b>Frequency not reported</b>: Bronchospasm, cough<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, fatigue </p><p><b>Uncommon</b> (0.1% to 1%): Tinnitus </p><p><b>Frequency not reported</b>: Fever, rigors<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Diaphoresis, rash<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Nonpuerperal lactation, increased micturition frequency</p><p>Genitourinary side effects have included nonpuerperal lactation in less than 0.3% of patients.  Increased micturition frequency has occurred with higher than recommended doses of rimantadine.</p><h3>Ocular</h3><p><b>Frequency not reported</b>: Lacrimation, eye pain</p><p id="ref_1">1. "Product Information. Flumadine (rimantadine)." Forest Pharmaceuticals, St. Louis, MO. </p><p id="ref_2">2. Centers for Disease Control and Prevention "Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP)." MMWR Morb Mortal Wkly Rep 47(RR-6) (1998): 1-26</p><p id="ref_3">3. Brady MT, Sears SD, Pacini DL, Samorodin R, DePamphilis J, Oakes M, Soo W, Clements ML "Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic." Antimicrob Agents Chemother 34 (1990): 1633-6</p><p id="ref_4">4. Jefferson T,  Demicheli V,  Rivetti D,  Jones M,  Di Pietrantonj C,  Rivetti A "Antivirals for influenza in healthy adults: systematic review." Lancet 367 (2006): 303-13</p><p id="ref_5">5. "Rimantadine for prevention and treatment of influenza." Med Lett Drugs Ther 35 (1993): 109-10</p><p id="ref_6">6. Patriarca PA, Kater NA, Kendal AP, Bregman DJ, Smith JD, Sikes RK "Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes." Antimicrob Agents Chemother 26 (1984): 101-3</p><p id="ref_7">7. Dolin R, Reichman RC, Madore HP, et al "A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection." N Engl J Med 307 (1982): 580-4</p><p id="ref_8">8. Millet VM, Dreisbach M, Bryson YJ "Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine." Antimicrob Agents Chemother 21 (1982): 1-4</p><p id="ref_9">9. Bentley DW, Karki SD, Betts RF "Rimantadine and seizures." Ann Intern Med 110 (1989): 323-4</p><p id="ref_10">10. Keyser LA, Karl M, Nafziger AN, Bertino JS "Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients." Arch Intern Med 160 (2000): 1485-8</p><p id="ref_11">11. Hayden FG, Hoffman HE, Spyker DA "Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics." Antimicrob Agents Chemother 23 (1983): 458-64</p><h2>More about rimantadine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: adamantane antivirals</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Rimantadine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Influenza A</li>
<li>Influenza Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>